S699 GLP-1 receptor agonists are associated with decreased esophageal cancer risk in type 2 diabetes patients compared to other anti-diabetic therapy

Khaled Alsabbagh Alchirazi; Ahmed El Telbany; Saqr Alsakarneh; Tarek Sawas

doi:10.14309/01.ajg.0001032164.05931.aa

S699 GLP-1 receptor agonists are associated with decreased esophageal cancer risk in type 2 diabetes patients compared to other anti-diabetic therapy

Khaled Alsabbagh Alchirazi
, Ahmed El Telbany
, Saqr Alsakarneh
, Tarek Sawas

Research output: Contribution to journal › Meeting abstract

Original language	American English
Journal	American Journal of Gastroenterology
DOIs	https://doi.org/10.14309/01.ajg.0001032164.05931.aa
Status	Published - Oct 1 2024

Access to Document

10.14309/01.ajg.0001032164.05931.aaLicense: Unspecified

http://institutionalrepository.aah.org/allother/1091

Cite this

@article{16e8890fdddc4b5b8a241c37b36f211a,

title = "S699 GLP-1 receptor agonists are associated with decreased esophageal cancer risk in type 2 diabetes patients compared to other anti-diabetic therapy",

author = "Alchirazi, \{Khaled Alsabbagh\} and Telbany, \{Ahmed El\} and Saqr Alsakarneh and Tarek Sawas",

year = "2024",

month = oct,

day = "1",

doi = "10.14309/01.ajg.0001032164.05931.aa",

language = "American English",

journal = "American Journal of Gastroenterology",

}

TY - JOUR

T1 - S699 GLP-1 receptor agonists are associated with decreased esophageal cancer risk in type 2 diabetes patients compared to other anti-diabetic therapy

AU - Alchirazi, Khaled Alsabbagh

AU - Telbany, Ahmed El

AU - Alsakarneh, Saqr

AU - Sawas, Tarek

PY - 2024/10/1

Y1 - 2024/10/1

U2 - 10.14309/01.ajg.0001032164.05931.aa

DO - 10.14309/01.ajg.0001032164.05931.aa

M3 - Meeting abstract

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

ER -